Lopirel (Clopidogrel) is an inhibitor of platelet aggregation. Lopirel (Clopidogrel) selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation.
Lopirel Tablet 75 mg
Prevention of artherosclerotic events in peripheral arterial disease or after myocardial infarction or ischaemic stroke: 75 mg once daily.
Acute coronary syndrome (without ST-segment elevation): initially 300 mg then 75 mg daily.
Acute myocardial infarction (with ST-segment elevation): initially 300 mg then 75 mg daily; initial dose omitted if patient over 75 years.